PHARMACOLOGIC MANAGEMENT OF ATHLETIC AMENORRHEA
- 1 April 1998
- journal article
- review article
- Published by Elsevier in Clinics in Sports Medicine
- Vol. 17 (2), 327-341
- https://doi.org/10.1016/s0278-5919(05)70084-3
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Bone-sparing properties of oral contraceptivesAmerican Journal of Obstetrics and Gynecology, 1996
- A Physician Survey of Therapy for Exercise-Associated AmenorrheaClinical Journal of Sport Medicine, 1995
- Body fat mass, body fat distribution, and pubertal development: a longitudinal study of physical and hormonal sexual maturation of girlsJournal of Clinical Endocrinology & Metabolism, 1992
- Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25-dihydroxyvitamin D3 and intestinal vitamin D receptor concentrations in normal womenJournal of Clinical Endocrinology & Metabolism, 1992
- Does Calcium Supplementation Prevent Postmenopausal Bone Loss?New England Journal of Medicine, 1987
- Scoliosis and Fractures in Young Ballet DancersNew England Journal of Medicine, 1986
- Aging decreases the capacity of human skin to produce vitamin D3.JCI Insight, 1985
- Induction of Menstrual Disorders by Strenuous Exercise in Untrained WomenNew England Journal of Medicine, 1985
- Bone Mineral Content of Amenorrheic and Eumenorrheic AthletesNew England Journal of Medicine, 1984
- TREATMENT OF POST MENOPAUSAL OSTEOPOROSIS. A CONTROLLED THERAPEUTIC TRIAL COMPARING OESTROGEN/GESTAGEN, 1,25‐DIHYDROXY‐VITAMIN D3 AND CALCIUMClinical Endocrinology, 1982